{
    "title": "Biogen plans late-stage Alzheimer's trial, shares rise",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2857764/Biogen-plans-late-stage-Alzheimers-trial-shares-rise.html",
    "date": "2014-12-02",
    "keywords": [
        "trial",
        "company",
        "brain",
        "biogen",
        "gmt",
        "december",
        "ransdell",
        "drug",
        "cognition",
        "phase",
        "role",
        "swelling",
        "class",
        "secretase",
        "johnson",
        "beta",
        "email",
        "piersondec",
        "incs",
        "research",
        "chief",
        "tuesday",
        "treatment",
        "cut",
        "plaque",
        "earlystage",
        "sclerosis",
        "percent",
        "midday",
        "trading",
        "deutsche",
        "bank",
        "conference",
        "data",
        "disease",
        "medicine",
        "protein",
        "buildup",
        "toxic",
        "hallmark",
        "alzheimerswe",
        "iii",
        "study",
        "spokeswoman",
        "kate",
        "niazisai",
        "presentationthe",
        "side",
        "issue",
        "bapineuzumab",
        "pfizer",
        "inc",
        "solanezumab",
        "gamma",
        "partner",
        "latestage",
        "solananezumab",
        "alzheimersone",
        "bace",
        "enzyme",
        "production",
        "amyloid",
        "co",
        "form",
        "dementia",
        "figure",
        "population",
        "reporting",
        "pierson",
        "von",
        "ahn",
        "marguerita",
        "choy"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}